7-Ketocholesterol and 7β-hydroxycholesterol: In vitro and animal models used to characterize their activities and to identify molecules preventing their toxicity.


Journal

Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032

Informations de publication

Date de publication:
03 2020
Historique:
received: 28 06 2019
accepted: 30 09 2019
pubmed: 7 10 2019
medline: 18 8 2020
entrez: 7 10 2019
Statut: ppublish

Résumé

Oxysterols are molecules derived by the oxidation of cholesterol and can be formed either by auto-oxidation, enzymatically or by both processes. Among the oxysterols formed by auto-oxidation, 7-ketocholesterol and 7β-hydroxycholesterol are the main forms generated. These oxysterols, formed endogenously and brought in large quantities by certain foods, have major cytotoxic properties. They are powerful inducers of oxidative stress, inducing dysfunction of organelles (mitochondria, lysosomes and peroxisomes) that can cause cell death. These molecules are often identified in increased amounts in common pathological states such as cardiovascular diseases, certain eye conditions, neurodegenerative disorders and inflammatory bowel diseases. To oppose the cytotoxic effects of these molecules, it is important to know their biological activities and the signaling pathways they affect. Numerous cell models of the vascular wall, eye, brain, and digestive tract have been used. Currently, to counter the cytotoxic effects of 7-ketocholesterol and 7β-hydroxycholesterol, natural molecules and oils, often associated with the Mediterranean diet, as well as synthetic molecules, have proved effective in vitro. Bioremediation approaches and the use of functionalized nanoparticles are also promising. At the moment, invertebrate and vertebrate models are mainly used to evaluate the metabolism and the toxicity of 7-ketocholesterol and 7β-hydroxycholesterol. The most frequently used models are mice, rats and rabbits. In order to cope with the difficulty of transferring the results obtained in animals to humans, the development of in vitro alternative methods such as organ/body-on-a-chip based on microfluidic technology are hopeful integrative approaches.

Identifiants

pubmed: 31586589
pii: S0006-2952(19)30347-8
doi: 10.1016/j.bcp.2019.113648
pii:
doi:

Substances chimiques

Hydroxycholesterols 0
Ketocholesterols 0
cholest-5-en-3 beta,7 alpha-diol 566-26-7
7-ketocholesterol O7676FE78M

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

113648

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Anne Vejux (A)

Université de Bourgogne Franche-Comté/Inserm, Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism' EA 7270, 21000 Dijon, France. Electronic address: anne.vejux@u-bourgogne.fr.

Dehbia Abed-Vieillard (D)

Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, UMR 6265 CNRS, UMR 1324 INRA, Université Bourgogne Franche-Comté, 21000 Dijon, France.

Khadija Hajji (K)

University Tunis El Manar, Faculty of Sciences of Tunis, LR18ES03, Laboratory of Neurophysiology, Cellular Physiopathology and Biomolecules Valorisation, Tunis, Tunisia.

Amira Zarrouk (A)

Faculty of Medicine, LR12ES05, Laboratory - NAFS "Nutrition - Functional Food & Vascular Health", Monastir, & University Sousse, Faculty of Medicine, Sousse, Tunisia.

John J Mackrill (JJ)

Department of Physiology, Biosciences Institute, University College Cork, Cork, Ireland.

Shubhrima Ghosh (S)

Enzyme and Microbial Biochemistry Laboratory, Department of Chemistry, Indian Institute of Technology, Delhi, New Delhi, India.

Thomas Nury (T)

Université de Bourgogne Franche-Comté/Inserm, Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism' EA 7270, 21000 Dijon, France.

Aline Yammine (A)

Bioactive Molecules Research Laboratory, Doctoral School of Sciences and Technologies, Faculty of Sciences, Lebanese University, Beirut 1103, Lebanon.

Mohamed Zaibi (M)

Clore Laboratory, University of Buckingham, Hunter Street, Buckingham, United Kingdom.

Wafa Mihoubi (W)

Centre de Biotechnologie de Sfax, Lab. Biotechnologie Moléculaire des Eucaryotes, Sfax, Tunisia.

Habiba Bouchab (H)

Laboratory of Biochemistry and Neurosciences, Department of Biology, University Hassan I, 26000 Settat, Morocco.

Boubker Nasser (B)

Laboratory of Biochemistry and Neurosciences, Department of Biology, University Hassan I, 26000 Settat, Morocco.

Yaël Grosjean (Y)

Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, UMR 6265 CNRS, UMR 1324 INRA, Université Bourgogne Franche-Comté, 21000 Dijon, France.

Gérard Lizard (G)

Université de Bourgogne Franche-Comté/Inserm, Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism' EA 7270, 21000 Dijon, France. Electronic address: gerard.lizard@u-bourgogne.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH